Nicole Drezner
8PUBLICATIONS
90CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 02, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.Kristin M Wessel, Katherine A Janeway, Lara E Davis
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|May 06, 2025
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better.Kristin M Wessel, Nicole Drezner, Stacy S Shord
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Dec 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco
Pageof 2
Frequent Collaborators
6 joint publications
Richard Pazdur
5 joint publications
Harpreet Singh
5 joint publications
Barbara Scepura
5 joint publications
Martha Donoghue
5 joint publications
Youwei Bi
4 joint publications
Paul G Kluetz
4 joint publications
Claudia P Miller
3 joint publications
Anup K Amatya
3 joint publications
Pallavi S Mishra-Kalyani
3 joint publications
Jeanne Fourie Zirkelbach
